[Distant bacillus Calmette-Guérin disease in an infant. Case report]

María V Peruffo1, Silvia A Maffia2, Gabriela Nainsztein2

  • 1Servicio de Terapia Intermedia, Sala 14, Hospital de Niños Sor María Ludovica, La Plata, Buenos Aires. mperuffo2304@yahoo.com.ar.

Insights

Bacillus Calmette-Guérin (BCG) dissemination is rare but can occur in infants. This case highlights BCG dissemination in a 5-month-old, successfully treated with antituberculous drugs.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • The bacillus Calmette-Guérin (BCG) vaccine prevents severe tuberculosis, administered to newborns in high-prevalence areas.
  • While generally safe, local complications like suppuration and adenopathy can occur.
  • Disseminated BCG disease is infrequent, typically seen in immunocompromised individuals.

Observation:

  • A 5-month-old infant presented with a two-month history of weight loss and subcutaneous nodules.
  • Clinical suspicion pointed towards bacillus Calmette-Guérin dissemination.
  • Diagnosis was confirmed via biopsy of the subcutaneous lesions.

Findings:

  • The infant's condition was diagnosed as bacillus Calmette-Guérin dissemination.
  • Treatment involved a three-drug antituberculous regimen.
  • The child showed clinical recovery following treatment.

Implications:

  • This case underscores the possibility of BCG dissemination even without identifiable immunodeficiency.
  • Early diagnosis and prompt antituberculous therapy are crucial for favorable outcomes.
  • Further research into risk factors for disseminated BCG disease is warranted.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
480
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
846
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
795